Regenxbio Inc (RGNX)
9.18
-0.45
(-4.67%)
USD |
NASDAQ |
Nov 21, 16:00
9.25
+0.07
(+0.76%)
After-Hours: 20:00
Regenxbio Price to Book Value: 1.509 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.509 |
| November 20, 2024 | 1.583 |
| November 19, 2024 | 1.571 |
| November 18, 2024 | 1.668 |
| November 15, 2024 | 1.583 |
| November 14, 2024 | 1.831 |
| November 13, 2024 | 1.754 |
| November 12, 2024 | 1.724 |
| November 11, 2024 | 1.900 |
| November 08, 2024 | 1.834 |
| November 07, 2024 | 1.839 |
| November 06, 2024 | 1.550 |
| November 05, 2024 | 1.466 |
| November 04, 2024 | 1.440 |
| November 01, 2024 | 1.445 |
| October 31, 2024 | 1.412 |
| October 30, 2024 | 1.453 |
| October 29, 2024 | 1.489 |
| October 28, 2024 | 1.542 |
| October 25, 2024 | 1.537 |
| October 24, 2024 | 1.574 |
| October 23, 2024 | 1.601 |
| October 22, 2024 | 1.576 |
| October 21, 2024 | 1.704 |
| October 18, 2024 | 1.824 |
| Date | Value |
|---|---|
| October 17, 2024 | 1.742 |
| October 16, 2024 | 1.767 |
| October 15, 2024 | 1.693 |
| October 14, 2024 | 1.676 |
| October 11, 2024 | 1.625 |
| October 10, 2024 | 1.527 |
| October 09, 2024 | 1.518 |
| October 08, 2024 | 1.571 |
| October 07, 2024 | 1.564 |
| October 04, 2024 | 1.597 |
| October 03, 2024 | 1.537 |
| October 02, 2024 | 1.630 |
| October 01, 2024 | 1.678 |
| September 30, 2024 | 1.724 |
| September 27, 2024 | 1.533 |
| September 26, 2024 | 1.516 |
| September 25, 2024 | 1.537 |
| September 24, 2024 | 1.591 |
| September 23, 2024 | 1.656 |
| September 20, 2024 | 1.659 |
| September 19, 2024 | 1.774 |
| September 18, 2024 | 1.778 |
| September 17, 2024 | 1.838 |
| September 16, 2024 | 1.808 |
| September 13, 2024 | 1.822 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.210
Minimum
May 24 2022
5.603
Maximum
Jan 14 2021
2.49
Average
2.175
Median
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 3.811 |
| EyePoint Pharmaceuticals Inc | 2.605 |
| Cassava Sciences Inc | 9.291 |
| Vertex Pharmaceuticals Inc | 7.420 |
| Sarepta Therapeutics Inc | 8.644 |
Price to Book Value Related Metrics
| PS Ratio | 5.202 |
| Price | 9.18 |
| Earnings Yield | -54.68% |
| Market Cap | 454.82M |